Corcept Therapeutics Competitors and Similar CompaniesClear all

Corcept Therapeutics's competitors and similar companies include ASLAN Pharmaceuticals and BeyondSpring.

	Corcept Therapeutics Corcept Therapeutics is a pharmaceutical company which discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders.	ASLAN Pharmaceuticals ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market.	BeyondSpring BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies.
Founding Date	Founding Date 1998	Founding Date N/A	Founding Date 2010
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech clinical research drug development life sciences oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma
Locations	Locations Menlo Park, US HQ	Locations SG HQ Collingwood, AU	Locations Florham Park, US HQ
Employees	Employees 20624% increase	Employees 35	Employees 6712% decrease
Valuation ($)	Valuation ($) 3.7 b	Valuation ($) 1.7 m	Valuation ($) 80.2 m
Financial
Revenue (est.)	Revenue (est.) $482.4m (FY, 2023)	Revenue (est.) $12m (FY, 2023)	Revenue (est.) $1.4m (FY, 2022)
Cost of goods	Cost of goods $6.5m (FY, 2023)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $475.9m (FY, 2023)	Gross profit $12m (FY, 2023)	Gross profit N/A
Net income	Net income $106.1m (FY, 2023)	Net income ($44.2m) (FY, 2023)	Net income ($36.3m) (FY, 2022)
Funding
Total funding raised	Total funding raised $ 80.1m	Total funding raised $ 100m	Total funding raised $ 36.1m